Case Studies
A New Dimension in SI Joint Fusion
“iFuse TORQ expands opportunities for SI joint stabilization”
*Consultant for SI-BONE, Inc.
- Provider
- Malcolm R. DeBaun, M.D.*
- Speciality
- Director of Orthopaedic Trauma Duke University
- Facility
- Duke University Hospital
- Bio
-
Fellowship: Orthopaedic Trauma, Harborview Medical Center, Seattle, WA Residency: Orthopaedic Surgery, Stanford University, CA Medical School: Stanford University School of Medicine, CA Malcolm DeBaun, MD is an Orthopaedic trauma surgeon at Duke University Hospital focusing on musculoskeletal innovation and surgical tactics for pelvis/acetabulum, periarticular and revision fracture surgery.
SI joint dysfunction after metastatic sarcoma
Patient History:
- 68 y/o male with metastatic liposarcoma
- Mets to right Ilium
- Underwent radiation therapy
- Presented with SI joint pain and physical examination consistent with SI joint dysfunction
- Positive response to diagnostic injection
- Temporary pain relief with SI joint injection (10 days
- Wanted to avoid open procedure
Surgical Treatment:
Percutaneous Right SI joint Fixation x 2 iFuse TORQ® implants
Post-op:1,2
- Tolerated procedure wel
- Immediate weight bearing as tolerated
- Marked pain improvement at 2 weeks post-op
- Patient very satisfied with minimally invasive option
- No assisted devices required
1Patient results may vary
2Data on file, STACI Study, SI-BONE, Inc.
Healthcare professionals should refer to the Instructions For Use for indications, contraindications, warnings, and precautions at https://si-bone.com/label.
There are potential risks associated with iFuse procedures. They may not be appropriate for all patients and all patients may not benefit.
For information about the risks, visit https://si-bone.com/risks.